Looking at 10 years of dry eye disease flares

Video
Conference|ARVO

Dr Christopher Starr discusses key points from his virtual ARVO 2021 presentation regarding dry eye disease flares, including a rapid readout assessment of 10 years' worth of world literature to analyze studies in which the inflammatory disease's condition are categorized.

Dr Christopher Starr of Weill Cornell Medicine, discusses an overview of his virtual ARVO 2021 presentation regarding dry eye disease flares, including a rapid readout assessment of 10 years' worth of world literature to analyze studies in which the inflammatory disease's condition are categorized.

See more ARVO content

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Related Content
A group of elderly women navigate a street in Europe. Concept image for age-related macular degeneration and geographic atrophy. Image credit: ©Zelma – stock.adobe.com

How patients navigate quality-of-life challenges associated with geographic atrophy

Lynda Charters
May 15th 2025
Article

Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States

A series of kidney scans. Concept image for retinal biomarker scan, kidney function, lupus and autoimmune disease. Image credit: ©Sved Oliver – stock.adobe.com

Retinal microvascular changes in patients with systemic lupus erythematosus: Importance of OCTA

Lynda Charters
May 12th 2025
Article

The biomarkers are especially crucial for patients with lupus nephritis

Isarna Therapeutics shares positive results from Phase 2 BETTER trial

Isarna Therapeutics shares positive results from Phase 2 BETTER trial

Sydney M Crago
May 7th 2025
Article
OPGX-LCA5 gene therapy phase 1/2 data support potential to restore meaningful vision

OPGX-LCA5 gene therapy phase 1/2 data support potential to restore meaningful vision

Lynda Charters
May 6th 2025
Article

Opus Genetics reveals promising 1-year results from OPGx-LCA5 gene therapy, showing sustained vision improvements in adults with LCA5 retinal degeneration.

Q&A: Gregory Moloney, FRANZCO, FRCSC, discusses the “monofocal plus” toric intraocular lens

Q&A: Gregory Moloney, FRANZCO, FRCSC, discusses the “monofocal plus” toric intraocular lens

Gregory Moloney, FRANZCO, FRCSC
May 6th 2025
Article

Research findings compare the rotational stability of a monofocal plus toric IOL with traditional toric lenses

An image of Salt Lake City. Historic downtown area. Concept image for 2025 Association for Research in Vision and Ophthalmology (ARVO). Image credit: ©pabrady63 – stock.adobe.com

Editorial Advisory Board members bring research findings to ARVO

Sydney M Crago
May 5th 2025
Article

Members of the Ophthalmology Times Europe, Ophthalmology Times and Modern Retina editorial advisory boards are present and presenting at the 2025 ARVO meeting

© 2025 MJH Life Sciences

All rights reserved.